Insulet Corp. | Ownership

Companies that own Insulet Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Management & Research Co.
8,613,666
14.6%
-12,172
0.09%
06/30/2018
Wellington Management Co. LLP
5,729,334
9.71%
-45,620
0.11%
06/30/2018
PRIMECAP Management Co.
4,953,472
8.4%
-200
0.35%
06/30/2018
The Vanguard Group, Inc.
4,934,924
8.36%
88,115
0.02%
06/30/2018
Capital Research & Management Co. (Global Investors)
4,602,733
7.8%
-561,222
0.09%
06/30/2018
BlackRock Fund Advisors
2,514,627
4.26%
-1,117,411
0.01%
06/30/2018
Frontier Capital Management Co. LLC
2,064,949
3.5%
-181,039
1.42%
06/30/2018
Fred Alger Management, Inc.
1,856,695
3.15%
-72,970
0.74%
06/30/2018
ClearBridge Investments LLC
1,727,484
2.93%
47,608
0.16%
06/30/2018
D. E. Shaw & Co. LP
1,533,443
2.6%
102,904
0.25%
06/30/2018

About Insulet

View Profile
Address
100 Nagog Park
Acton Massachusetts 01720
United States
Employees -
Website http://www.myomnipod.com
Updated 07/08/2019
Insulet Corp. is an innovative medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L.